HU216731B - Modafinil alkalmazása alvási apnoe és központi eredetű légzészavarok kezelésére szolgáló gyógyászati készítmény előállítására - Google Patents

Modafinil alkalmazása alvási apnoe és központi eredetű légzészavarok kezelésére szolgáló gyógyászati készítmény előállítására Download PDF

Info

Publication number
HU216731B
HU216731B HU9503702A HU9503702A HU216731B HU 216731 B HU216731 B HU 216731B HU 9503702 A HU9503702 A HU 9503702A HU 9503702 A HU9503702 A HU 9503702A HU 216731 B HU216731 B HU 216731B
Authority
HU
Hungary
Prior art keywords
modafinil
treatment
apnea
sleep
pharmaceutical compositions
Prior art date
Application number
HU9503702A
Other languages
English (en)
Hungarian (hu)
Other versions
HUT74674A (en
HU9503702D0 (en
Inventor
Philippe Laurent
Original Assignee
Laboratoire L. Lafon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9448411&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HU216731(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoire L. Lafon filed Critical Laboratoire L. Lafon
Publication of HU9503702D0 publication Critical patent/HU9503702D0/hu
Publication of HUT74674A publication Critical patent/HUT74674A/hu
Publication of HU216731B publication Critical patent/HU216731B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Control Of Throttle Valves Provided In The Intake System Or In The Exhaust System (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU9503702A 1993-06-22 1994-06-14 Modafinil alkalmazása alvási apnoe és központi eredetű légzészavarok kezelésére szolgáló gyógyászati készítmény előállítására HU216731B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9307555A FR2706767B1 (enExample) 1993-06-22 1993-06-22

Publications (3)

Publication Number Publication Date
HU9503702D0 HU9503702D0 (en) 1996-02-28
HUT74674A HUT74674A (en) 1997-01-28
HU216731B true HU216731B (hu) 1999-08-30

Family

ID=9448411

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9503702A HU216731B (hu) 1993-06-22 1994-06-14 Modafinil alkalmazása alvási apnoe és központi eredetű légzészavarok kezelésére szolgáló gyógyászati készítmény előállítására

Country Status (14)

Country Link
US (1) US5612379A (enExample)
EP (1) EP0705099B1 (enExample)
JP (1) JP3703831B2 (enExample)
KR (1) KR100315389B1 (enExample)
AT (1) ATE207351T1 (enExample)
AU (1) AU684087B2 (enExample)
CA (1) CA2165824C (enExample)
DE (1) DE69428791T2 (enExample)
DK (1) DK0705099T3 (enExample)
ES (1) ES2165878T3 (enExample)
FR (1) FR2706767B1 (enExample)
HU (1) HU216731B (enExample)
PT (1) PT705099E (enExample)
WO (1) WO1995000132A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
JP2002504510A (ja) 1998-02-27 2002-02-12 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ 睡眠時無呼吸に対する処置のための、セロトニン関連活性を有する薬剤
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
US6492396B2 (en) 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
JP4593074B2 (ja) * 2000-10-11 2010-12-08 セフアロン・インコーポレーテツド モダフィニル化合物含有組成物
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
US7297346B2 (en) * 2001-05-25 2007-11-20 Cephalon Inc. Pharmaceutical formulations of modafinil
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040048931A1 (en) 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
IL153098A0 (en) * 2002-11-26 2003-06-24 Chemagis Ltd Pharmaceutical compositions containing modafinil
US7528172B2 (en) * 2003-01-21 2009-05-05 The Cooper Health System, Inc. Compositions and methods for improving recovery after general anesthesia
ES2487415T3 (es) * 2003-03-17 2014-08-20 Neurohealing Pharmaceuticals, Inc. Tratamiento dopaminérgico de alta potencia de deficiencias neurológicas asociadas con lesiones cerebrales
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
EP1586560A1 (en) * 2004-04-13 2005-10-19 Cephalon, Inc. Thio-substituted arylmethanesulfinyl derivatives
US7423176B2 (en) * 2004-04-13 2008-09-09 Cephalon, Inc. Bicyclic aromatic sulfinyl derivatives
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
US7314875B2 (en) * 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
US7297817B2 (en) * 2004-04-13 2007-11-20 Cephalon France Thio-substituted arylmethanesulfinyl derivatives
WO2006069030A1 (en) * 2004-12-20 2006-06-29 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
AU2006272874B2 (en) * 2005-07-21 2010-03-11 Neurohealing Pharmaceuticals, Inc. Rapid onset and short term modafinil compositions and methods of use thereof
BRPI0714173A2 (pt) * 2006-07-12 2012-12-25 Elan Pharma Int Ltd composiÇço nanoparticulada estÁvel,mÉtodos para preparar a composiÇço, para prevenir e/ou tratar estados de doenÇas, sintomas, sÍndromes e condiÇÕes do sistema nervoso central, para melhorar ou manter a biodisponibilidade de modafinil, e para tratar distérbio com base neurolàgica, composiÇço farmacÊutica, e forma de dosagem
JP5395663B2 (ja) 2006-08-14 2014-01-22 ニューロヒーリング・ファーマシューティカルズ・インコーポレーテッド モダフィニルによる早漏の治療
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
CN101641090B (zh) * 2006-12-19 2012-12-05 亚勒斯有限公司 莫达非尼在制备治疗多动腿综合征的药物中的应用
AU2011203970A1 (en) * 2010-01-07 2012-07-12 Vivus, Inc. Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent
ES2871381T3 (es) 2013-08-30 2021-10-28 Green Cross Wellbeing Corp Composición para prevenir y tratar la fatiga relacionada con el cáncer, que contiene polvo de ginseng procesado o extracto de ginseng procesado que tiene un componente de ginsenósido mejorado
US9616068B2 (en) 2014-10-27 2017-04-11 Pohela LLC Animal training using cognitive enhancement

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
FR2684875B1 (fr) * 1991-12-13 1995-05-24 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.
US5281607B1 (en) * 1992-10-08 1998-05-19 Univ New York Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
ATE207351T1 (de) 2001-11-15
KR100315389B1 (ko) 2002-02-19
JP3703831B2 (ja) 2005-10-05
WO1995000132A1 (fr) 1995-01-05
CA2165824C (fr) 2005-08-02
KR960703009A (ko) 1996-06-19
PT705099E (pt) 2002-03-28
AU7076094A (en) 1995-01-17
CA2165824A1 (fr) 1995-01-05
DE69428791D1 (de) 2001-11-29
EP0705099A1 (fr) 1996-04-10
EP0705099B1 (fr) 2001-10-24
JPH09500374A (ja) 1997-01-14
ES2165878T3 (es) 2002-04-01
AU684087B2 (en) 1997-12-04
FR2706767A1 (enExample) 1994-12-30
DE69428791T2 (de) 2002-07-04
HUT74674A (en) 1997-01-28
US5612379A (en) 1997-03-18
HU9503702D0 (en) 1996-02-28
DK0705099T3 (da) 2002-02-11
FR2706767B1 (enExample) 1995-09-08

Similar Documents

Publication Publication Date Title
HU216731B (hu) Modafinil alkalmazása alvási apnoe és központi eredetű légzészavarok kezelésére szolgáló gyógyászati készítmény előállítására
Taranto-Montemurro et al. The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity. A randomized, placebo-controlled, double-blind crossover trial
Becker et al. Reversal of sinus arrest and atrioventricular conduction block in patients with sleep apnea during nasal continuous positive airway pressure.
Block et al. Sleep-disordered breathing and nocturnal oxygen desaturation in postmenopausal women
Chan et al. Nocturnal asthma: role of snoring and obstructive sleep apnea
Whyte et al. Role of protriptyline and acetazolamide in the sleep apnea/hypopnea syndrome
Lavie et al. Nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis patients. Lack of association between clinical improvement and effects on sleep
Guilleminault et al. From apnea of infancy to obstructive sleep apnea syndrome in the young child
Stepanski et al. A double-blind trial of protriptyline in the treatment of sleep apnea syndrome
EP1715859B1 (en) Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method
Abe et al. Sleep Quality and Comfort Reported by Sleep Bruxism Individuals Wearing the Occlusal Splint and Mandibular Advancement Splint: Revisiting Two Crossover Studies.
JP2501033B2 (ja) Ｄ―フェンフルラミン含有うつ病用医薬組成物
Sanders et al. The acute effects of uvulopalatopharyngoplasty on breathing during sleep in sleep apnea patients
Schneider et al. The effect of triazolam and flunitrazepam—two benzodiazepines with different half-lives—on breathing during sleep
CA3016110C (en) Sultiame for the treatment of sleep apnea
Brander et al. Nocturnal oxygen saturation and sleep quality in patients with advanced chronic obstructive pulmonary disease during treatment with moderate dose CR-theophylline
Middleton Temazepam (Euhypnos®) and chlormethiazole: a comparative study in geriatric patients
Pankow et al. Continuous positive airway pressure lowers blood pressure in hypertensive patients with obstructive sleep apnea
Hirekar et al. Precision Medicine in Obstructive Sleep Apnea
Schmickl et al. 0567 Side Effects of Acetazolamide-A Systematic Review and Meta-Analysis Assessing Overall Risk and Dose-Dependence
KR20250000641A (ko) 수면장애 및/또는 수면장애 관련 질환을 예방, 개선 또는 치료하는 방법
Guilleminault et al. Infant obstructive sleep apnea, near-miss sudden infant death syndrome, and the development of obstructive sleep apnea syndrome
Schredl et al. Sleep quality in patients with panic disorder: Relationship to nocturnal panic attacks
Grote et al. Clinical investigation: effect of angiotensin converting enzyme inhibition [Cilazapril] on blood pressure recording in hypertensive obstructive sleep apneic patients
Trenkwalder et al. 3-50-02 An unusual case of idiopathic recurrent stupor with circadian rhythm—A new entity of the disease?